Patent ID: 8338623

Claim:
A compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein A is formula (v) wherein formula (v) is independently unsubstituted or further substituted with 1 or 2 substituents independently selected from the group consisting of alkyl or halogen; R 1 is hydrogen, alkyl, or haloalkyl; R 2 is alkyl, alkenyl, alkynyl, G 1 , —N(R b )(R f ), —(CR d R e ) m —CN, —(CR d R e ) n —OR f , —(CR d R e ) n —S(R c ), —(CR d R e ) m —S(O) 2 R c , —(CR d R e ) n —N(R b )(R f ), —(CR d R e ) m —C(O)R b , —(CR d R e ) m —C(O)O(R b ), —(CR d R e ) m -G 1 , or haloalkyl; or R 1 and R 2 , together with the nitrogen atom to which they are attached, form a 4- to 6-membered monocyclic heterocycle containing zero or one additional heteroatom selected from the group consisting of O, or S, and two non-adjacent atoms of said monocyclic heterocycle are optionally linked by an alkylene bridge of 1-4 carbon atoms, said monocyclic heterocycle is optionally substituted with 1, or 2 substituents independently selected from the group consisting of alkyl, halogen, oxo, —OR a , haloalkyl; G 1 , at each occurrence, is independently aryl, heteroaryl, heterocycle, cycloalkyl, or cycloalkenyl; wherein each G 1 is independently unsubstituted or further substituted with 1, 2, or 3 substituents independently selected from the group consisting of alkyl, alkenyl, alkynyl, halogen, oxo, —CN, —NO 2 , OR a , —S(R c ), —S(O)(R c ), —S(O) 2 R c , —S(O) 2 N(R b ) 2 , C(O)R b , —C(O)O(R b ), —C(O)N(R b ) 2 , —N(R b ) 2 , —N(R b )C(O)R b , —N(R b )C(O)O(R b ), —N(R b )S(O) 2 R c , haloalkyl, —(CR d R e ) m —OR a , —(CR d R e ) m —S(R c ), and —(CR d R e ) m —S(O)(R c ); R a , at each occurrence, is independently hydrogen, alkyl, haloalkyl, or —(CR d R e ) m —O(alkyl), R b , at each occurrence, is independently hydrogen, alkyl, or haloalkyl; R c , at each occurrence, is independently alkyl or haloalkyl; R f , at each occurrence, is independently hydrogen, alkyl, G 1 , —(CR d R e ) m -G 1 , or haloalkyl; R d and R e , at each occurrence, are each independently hydrogen, halogen, alkyl, or haloalkyl; m, at each occurrence, is independently 1, 2, 3, 4, 5, or 6; n, at each occurrence, is independently 2, 3, 4, 5, or 6; R 3 is formula (a) or (b), wherein formula (a) and (b) are each independently unsubstituted or further substituted with 1 or 2 substituents independently selected from the group consisting of alkyl, halogen, oxo, —CN, —O(alkyl), and haloalkyl.